BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28859986)

  • 1. KRIBB11 accelerates Mcl-1 degradation through an HSF1-independent, Mule-dependent pathway in A549 non-small cell lung cancer cells.
    Kang MJ; Yun HH; Lee JH
    Biochem Biophys Res Commun; 2017 Oct; 492(3):304-309. PubMed ID: 28859986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRIBB11 Induces Apoptosis in A172 Glioblastoma Cells via MULE-Dependent Degradation of MCL-1.
    Yoo K; Yun HH; Jung SY; Lee JH
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRIBB11 inhibits HSP70 synthesis through inhibition of heat shock factor 1 function by impairing the recruitment of positive transcription elongation factor b to the hsp70 promoter.
    Yoon YJ; Kim JA; Shin KD; Shin DS; Han YM; Lee YJ; Lee JS; Kwon BM; Han DC
    J Biol Chem; 2011 Jan; 286(3):1737-47. PubMed ID: 21078672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase cleavage of Mcl-1 impairs its anti-apoptotic activity and proteasomal degradation in non-small lung cancer cells.
    Wang T; Yang Z; Zhang Y; Zhang X; Wang L; Zhang S; Jia L
    Apoptosis; 2018 Jan; 23(1):54-64. PubMed ID: 29256070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction.
    Gomez-Bougie P; Ménoret E; Juin P; Dousset C; Pellat-Deceunynck C; Amiot M
    Biochem Biophys Res Commun; 2011 Sep; 413(3):460-4. PubMed ID: 21907705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic-Induced Apoptosis.
    Antonietti P; Linder B; Hehlgans S; Mildenberger IC; Burger MC; Fulda S; Steinbach JP; Gessler F; Rödel F; Mittelbronn M; Kögel D
    Mol Cancer Ther; 2017 Jan; 16(1):156-168. PubMed ID: 27777286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells.
    Kang XH; Zhang JH; Zhang QQ; Cui YH; Wang Y; Kou WZ; Miao ZH; Lu P; Wang LF; Xu ZY; Cao F
    Cell Physiol Biochem; 2017; 41(5):2067-2076. PubMed ID: 28419994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters.
    Kim JA; Kim Y; Kwon BM; Han DC
    J Biol Chem; 2013 Oct; 288(40):28713-26. PubMed ID: 23983126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia.
    Ishikawa C; Mori N
    Med Oncol; 2023 May; 40(6):172. PubMed ID: 37165174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.
    Park SH; Lee DH; Kim JL; Kim BR; Na YJ; Jo MJ; Jeong YA; Lee SY; Lee SI; Lee YY; Oh SC
    Oncotarget; 2016 Sep; 7(37):59503-59518. PubMed ID: 27517746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70.
    Stankiewicz AR; Livingstone AM; Mohseni N; Mosser DD
    Cell Death Differ; 2009 Apr; 16(4):638-47. PubMed ID: 19148187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action.
    Petsri K; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31117253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer.
    Ye M; Zhang Y; Zhang X; Zhang J; Jing P; Cao L; Li N; Li X; Yao L; Zhang J; Zhang J
    Cancer Res; 2017 Jul; 77(13):3527-3539. PubMed ID: 28522751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation.
    Koo J; Yue P; Deng X; Khuri FR; Sun SY
    Mol Cell Biol; 2015 Jul; 35(13):2344-55. PubMed ID: 25918246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PI3 kinase inhibitor NVP-BKM120 induces GSK3/FBXW7-dependent Mcl-1 degradation, contributing to induction of apoptosis and enhancement of TRAIL-induced apoptosis.
    Ren H; Zhao L; Li Y; Yue P; Deng X; Owonikoko TK; Chen M; Khuri FR; Sun SY
    Cancer Lett; 2013 Sep; 338(2):229-38. PubMed ID: 23562472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chidamide Inhibits Aerobic Metabolism to Induce Pancreatic Cancer Cell Growth Arrest by Promoting Mcl-1 Degradation.
    He M; Qiao Z; Wang Y; Kuai Q; Li C; Wang Y; Jiang X; Wang X; Li W; He M; Ren S; Yu Q
    PLoS One; 2016; 11(11):e0166896. PubMed ID: 27875574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fisetin, a dietary flavonoid, induces apoptosis of cancer cells by inhibiting HSF1 activity through blocking its binding to the hsp70 promoter.
    Kim JA; Lee S; Kim DE; Kim M; Kwon BM; Han DC
    Carcinogenesis; 2015 Jun; 36(6):696-706. PubMed ID: 25840992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin attenuates CHIP-guarded HSF1 nuclear translocation and protein stability to trigger IGF-IIR-dependent cardiomyocyte death.
    Huang CY; Kuo WW; Lo JF; Ho TJ; Pai PY; Chiang SF; Chen PY; Tsai FJ; Tsai CH; Huang CY
    Cell Death Dis; 2016 Nov; 7(11):e2455. PubMed ID: 27809308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E3 ubiquitin ligases β-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis.
    Ren H; Koo J; Guan B; Yue P; Deng X; Chen M; Khuri FR; Sun SY
    Mol Cancer; 2013 Nov; 12():146. PubMed ID: 24261825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.
    Wang CY; Guo ST; Croft A; Yan XG; Jin L; Zhang XD; Jiang CC
    Mol Carcinog; 2018 Feb; 57(2):284-294. PubMed ID: 29068469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.